about
Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library.Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library.Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.Protective activity of the CnaBE3 domain conserved among Staphylococcus aureus Sdr proteins.Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In Vitro.Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature.Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenesPolio elimination in Nigeria: A reviewLarge oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit.Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents.Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy.Prevalence of M75 Streptococcus pyogenes Strains Harboring slaA Gene in Patients Affected by Pediatric Obstructive Sleep Apnea Syndrome in Central Italy.Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine.Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy.First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host.Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients.HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent hostStaphylococcus aureus vaccine preclinical and clinical development: current state of the artDistribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremiaErythromycin Resistance in Streptococcus pyogenes and Macrolide Consumption in a Central Italian RegionAntimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: surveillance from 1993 to 2004 in Central ItalySerotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategiesAntipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacinPhacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological studyUse of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infectionUse of miltefosine in a patient with mucosal leishmaniasis and HIV-coinfection: a challenge in long-term managementClinical and molecular characterization of COVID-19 hospitalized patientsLaboratory diagnosis of Mycoplasma pneumoniae infections: data analysis from clinical practice
P50
Q30852157-A197C690-3F8C-40BE-BDD5-013AC5FF686AQ33253834-9F08115C-7B52-4A33-8877-FF694C39302CQ33311002-893BB4EC-5AD9-44E1-9658-6341FACEA111Q34109184-1742260B-062A-45F4-9714-FFF5E209411AQ34999275-4B41181F-1089-4853-B0D4-D662BAE27BA8Q35661171-57154ECE-61D8-457B-9B3E-5811D6509D2EQ36040140-0C2BFF7D-05C2-4322-A329-570498C27630Q36460399-5D90C5A1-151B-4E95-9621-0995FBB7106BQ36565162-994E4225-6DF9-435E-BFA6-8E6509681E2FQ37135154-46D9AB92-BDC7-4E2C-B703-5AE8442E78B6Q37336188-1B3ABAF8-6646-4608-B612-A5926BD6C942Q37789523-CDC32049-C98E-4852-8054-13DC914D68E4Q39622372-BCC4818B-D9AB-4F9E-B5A9-A8D01502FA34Q40292530-D2BD47C1-8280-4E1A-BB1B-368EFAE3966DQ40935552-667FEFC7-D959-47E1-A18D-0D6B9F823F47Q41082176-8B699FBE-64B6-41D5-AC0B-7C11EB55D51BQ42199504-12820C3A-F7E4-439A-9B13-96E48B908BE4Q44641281-3F7866B7-9F99-425B-99EE-EDA02B4B9569Q50262252-E4B31D2C-E418-4EB5-A48B-CD4DA3DE4A4FQ52574609-8D55433D-CF05-4508-A7CA-8F6B8AFC080BQ52719338-585C7DB7-2D16-4F10-9B65-5092834246E5Q57027394-C0427DB2-A34A-4964-9989-9FC3BAE09859Q57178752-31CCFEDE-746A-4639-936E-69C65F5EF318Q59351950-154B26E5-2763-49AF-BBF3-D7E07304AEA1Q63762234-413693A6-A5DD-481E-A578-B09C1F85CBB7Q79197974-88673EFD-58CA-4C00-8784-04D7A0A240F2Q79394629-9826430F-FEA0-4EC1-B7CD-A4C5A09B5478Q82060191-219854B2-5F02-4D86-94EF-5FDBB7FD1F2CQ84498756-CCA51EA6-EB31-40FF-98BA-59A840D44701Q84569790-BD0F1464-4C9B-4625-9196-8FEB83F4F0EDQ92047379-4A503A1F-34E5-401F-BDD8-D636D33A7621Q95602273-C12A1239-62F6-4746-B6D8-CDA41C9A2226Q95693770-C7727B1C-83F8-49E3-B30F-6672C12EB1C2
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-2267-1337
@en
name
Francesca Montagnani
@ast
Francesca Montagnani
@en
Francesca Montagnani
@es
Francesca Montagnani
@nl
type
label
Francesca Montagnani
@ast
Francesca Montagnani
@en
Francesca Montagnani
@es
Francesca Montagnani
@nl
prefLabel
Francesca Montagnani
@ast
Francesca Montagnani
@en
Francesca Montagnani
@es
Francesca Montagnani
@nl
P106
P1153
36840499700
P21
P31
P496
0000-0002-2267-1337